IGF2BP1 and non-small cell lung carcinoma: In vitro studies of NSCLC cells treated with high glucose dosages showed that the RNA-binding protein insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) was highly expressed in high-glucose-treated NSCLC cells.